Eric A. Md Rose - May 17, 2023 Form 4 Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)

Role
Director
Signature
/s/ Matthew R. Schob, Attorney-in-Fact
Stock symbol
OBIO
Transactions as of
May 17, 2023
Transactions value $
-$7
Form type
4
Date filed
5/19/2023, 06:15 PM
Previous filing
Jan 30, 2023
Next filing
Jul 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OBIO Common Stock, par value $0.0001 per share ("Common Stock") Options Exercise $2.51K +2.33K $1.08* 2.33K May 17, 2023 Direct F1
transaction OBIO Common Stock Tax liability -$2.52K -157 -6.75% $16.04 2.17K May 17, 2023 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OBIO Warrant (Right to Buy) Options Exercise $0 -2.33K -100% $0.00* 0 May 17, 2023 Common Stock 2.33K $1.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 17, 2023, the Reporting Person exercised a warrant to purchase 2,325 shares of Common Stock at an exercise price $1.08 per share. The Reporting Person paid the exercise price on a cashless basis, resulting in Orchestra BioMed Holdings, Inc. (the "Issuer") withholding 157 of the warrant shares to pay the exercise price and issuing the Reporting Person the remaining 2,168 shares of Common Stock.
F2 Represents the shares of Common Stock deemed withheld by the Issuer in connection with the cashless exercise.
F3 Pursuant to Section 3(c) of the warrant, the price was calculated as the average closing price per share of Common Stock for the 20 trading days immediately preceding the date on which the notice of exercise was deemed to have been sent to the Issuer.